Anti-GMO Study is “Inadequate”

The European Food Safety Authority is unconvinced by a study linking genetically modified crops to cancer and early death.

Written byBeth Marie Mole
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Wikimedia, GardenkittyThe European Food Safety Authority (EFSA) has found that a controversial study, which claimed to link genetically modified (GM) crops to early death and tumor development in rats, is not scientifically valid or useful in assessing health risks, according to a statement released last week (October 4).

The study, published September 19 in Food and Chemical Toxicology and authored by Gilles-Eric Séralini of the University of Caen in France and colleagues, claimed that rats fed GM corn—which is approved for use in Europe and America—developed massive mammary tumors and died earlier than rats fed conventional corn during a two year study. But scientific experts swiftly pointed out flaws in the study’s design and analysis. The day after its publication, the EFSA announced that it would create a task force to evaluate the study and any possible risks to public health it reported.

The results of that audit found that the study “is of insufficient scientific quality to be considered as valid for risk assessment.” And that the “initial review found that the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies